Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Ancestral gene regulatory networks drive cancer.

Bussey KJ, Cisneros LH, Lineweaver CH, Davies PCW.

Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):6160-6162. doi: 10.1073/pnas.1706990114. Epub 2017 Jun 5. No abstract available.

2.

Ancient genes establish stress-induced mutation as a hallmark of cancer.

Cisneros L, Bussey KJ, Orr AJ, Miočević M, Lineweaver CH, Davies P.

PLoS One. 2017 Apr 25;12(4):e0176258. doi: 10.1371/journal.pone.0176258. eCollection 2017.

3.

Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett's esophagus.

Zeng J, Kelbauskas L, Rezaie A, Lee K, Ueberroth B, Gao W, Derkach D, Tran T, Smith D, Bussey KJ, Meldrum DR.

Sci Rep. 2016 Oct 12;6:35227. doi: 10.1038/srep35227.

4.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 Aug 8;30(2):363. doi: 10.1016/j.ccell.2016.07.013. Epub 2016 Aug 8. No abstract available.

5.

Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells.

Nandakumar V, Hansen N, Glenn HL, Han JH, Helland S, Hernandez K, Senechal P, Johnson RH, Bussey KJ, Meldrum DR.

Sci Rep. 2016 Aug 9;6:30593. doi: 10.1038/srep30593.

6.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW.

Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Erratum in: Cancer Cell. 2016 Aug 8;30(2):363.

7.

Pathway Implications of Aberrant Global Methylation in Adrenocortical Cancer.

Legendre CR, Demeure MJ, Whitsett TG, Gooden GC, Bussey KJ, Jung S, Waibhav T, Kim S, Salhia B.

PLoS One. 2016 Mar 10;11(3):e0150629. doi: 10.1371/journal.pone.0150629. eCollection 2016.

8.

Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma.

Bussey KJ, Bapat A, Linnehan C, Wandoloski M, Dastrup E, Rogers E, Gonzales P, Demeure MJ.

Clin Transl Med. 2016 Mar;5(1):1. doi: 10.1186/s40169-015-0080-3. Epub 2016 Jan 11.

9.

Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.

Demeure MJ, Aziz M, Rosenberg R, Gurley SD, Bussey KJ, Carpten JD.

World J Surg. 2014 Jun;38(6):1296-305. doi: 10.1007/s00268-014-2485-3.

PMID:
24633422
10.

PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.

Demeure MJ, Coan KE, Grant CS, Komorowski RA, Stephan E, Sinari S, Mount D, Bussey KJ.

Surgery. 2013 Dec;154(6):1405-16; discussion 1416. doi: 10.1016/j.surg.2013.06.058.

11.

Detection of an atypical teratoid rhabdoid brain tumor gene deletion in circulating blood using next-generation sequencing.

Chakravadhanula M, Tembe W, Legendre C, Carpentieri D, Liang WS, Bussey KJ, Carpten J, Berens ME, Bhardwaj RD.

J Child Neurol. 2014 Sep;29(9):NP81-5. doi: 10.1177/0883073813503904. Epub 2013 Oct 17.

PMID:
24141276
12.

A fly in the ointment: reassessing mitotane's role in the treatment of adrenocortical carcinoma.

Bapat AA, Demeure MJ, Bussey KJ.

Pharmacogenomics. 2012 Aug;13(11):1207-9. doi: 10.2217/pgs.12.90. No abstract available.

13.

Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling.

Creamer MS, Stites EC, Aziz M, Cahill JA, Tan CW, Berens ME, Han H, Bussey KJ, Von Hoff DD, Hlavacek WS, Posner RG.

BMC Syst Biol. 2012 Aug 22;6:107. doi: 10.1186/1752-0509-6-107.

14.

Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations.

Nandakumar V, Kelbauskas L, Hernandez KF, Lintecum KM, Senechal P, Bussey KJ, Davies PC, Johnson RH, Meldrum DR.

PLoS One. 2012;7(1):e29230. doi: 10.1371/journal.pone.0029230. Epub 2012 Jan 5.

15.

Targeted therapies for adrenocortical carcinoma: IGF and beyond.

Demeure MJ, Bussey KJ, Kirschner LS.

Horm Cancer. 2011 Dec;2(6):385-92. doi: 10.1007/s12672-011-0090-6. Review.

PMID:
22170383
16.

Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.

Demeure MJ, Stephan E, Sinari S, Mount D, Gately S, Gonzales P, Hostetter G, Komorowski R, Kiefer J, Grant CS, Han H, Von Hoff DD, Bussey KJ.

Ann Surg. 2012 Jan;255(1):140-6. doi: 10.1097/SLA.0b013e3182402d21.

PMID:
22156929
17.

Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.

Baehner FL, Lee M, Demeure MJ, Bussey KJ, Kiefer JA, Barrett MT.

J Surg Oncol. 2011 May 1;103(6):563-73. doi: 10.1002/jso.21838. Review.

PMID:
21480251
18.

Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.

Bussey KJ, Demeure MJ.

Curr Opin Oncol. 2011 Jan;23(1):34-44. doi: 10.1097/CCO.0b013e328340d879. Review.

PMID:
21045685
19.

Multi-institutional tumor banking: lessons learned from a pancreatic cancer biospecimen repository.

Demeure MJ, Sielaff T, Koep L, Prinz R, Moser AJ, Zeh H 3rd, Hostetter G, Black J, Decker A, Rosewell S, Bussey KJ, Von Hoff D.

Pancreas. 2010 Oct;39(7):949-54. doi: 10.1097/MPA.0b013e3181df27a8. Review.

PMID:
20861694
20.

Multifactorial regulation of E-cadherin expression: an integrative study.

Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN.

Mol Cancer Ther. 2010 Jan;9(1):1-16. doi: 10.1158/1535-7163.MCT-09-0321. Epub 2010 Jan 6.

21.

Adrenocortical cancer.

Wandoloski M, Bussey KJ, Demeure MJ.

Surg Clin North Am. 2009 Oct;89(5):1255-67. doi: 10.1016/j.suc.2009.06.019. Review.

PMID:
19836496
22.

Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.

Bussey KJ, Demeure MJ.

Future Oncol. 2009 Jun;5(5):641-55. doi: 10.2217/fon.09.45. Review.

PMID:
19519204
23.

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.

Lorenzi PL, Reinhold WC, Rudelius M, Gunsior M, Shankavaram U, Bussey KJ, Scherf U, Eichler GS, Martin SE, Chin K, Gray JW, Kohn EC, Horak ID, Von Hoff DD, Raffeld M, Goldsmith PK, Caplen NJ, Weinstein JN.

Mol Cancer Ther. 2006 Nov;5(11):2613-23. Epub 2006 Nov 6.

24.

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.

Bussey KJ, Chin K, Lababidi S, Reimers M, Reinhold WC, Kuo WL, Gwadry F, Ajay, Kouros-Mehr H, Fridlyand J, Jain A, Collins C, Nishizuka S, Tonon G, Roschke A, Gehlhaus K, Kirsch I, Scudiero DA, Gray JW, Weinstein JN.

Mol Cancer Ther. 2006 Apr;5(4):853-67.

25.

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

Szakács G, Annereau JP, Lababidi S, Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD, Reimers M, Weinstein JN, Gottesman MM.

Cancer Cell. 2004 Aug;6(2):129-37.

26.

Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics.

Zeeberg BR, Riss J, Kane DW, Bussey KJ, Uchio E, Linehan WM, Barrett JC, Weinstein JN.

BMC Bioinformatics. 2004 Jun 23;5:80.

27.

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.

Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, Reinhold WC, Papp A, Weinstein JN, Sadée W.

Cancer Res. 2004 Jun 15;64(12):4294-301.

28.

Karyotypic complexity of the NCI-60 drug-screening panel.

Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN, Kirsch IR.

Cancer Res. 2003 Dec 15;63(24):8634-47.

29.

Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells.

Lee JK, Bussey KJ, Gwadry FG, Reinhold W, Riddick G, Pelletier SL, Nishizuka S, Szakacs G, Annereau JP, Shankavaram U, Lababidi S, Smith LH, Gottesman MM, Weinstein JN.

Genome Biol. 2003;4(12):R82. Epub 2003 Nov 25.

30.

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.

Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E 3rd, Liotta LA, Weinstein JN.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14229-34. Epub 2003 Nov 17.

31.

Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling.

Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, Bussey KJ, Kim S, Lababidi S, Lee JK, Pittaluga S, Scudiero DA, Sausville EA, Munson PJ, Petricoin EF 3rd, Liotta LA, Hewitt SM, Raffeld M, Weinstein JN.

Cancer Res. 2003 Sep 1;63(17):5243-50.

32.

GoMiner: a resource for biological interpretation of genomic and proteomic data.

Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, Weinstein JN.

Genome Biol. 2003;4(4):R28. Epub 2003 Mar 25.

33.

MatchMiner: a tool for batch navigation among gene and gene product identifiers.

Bussey KJ, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold WC, Zeeberg B, Ajay W, Weinstein JN.

Genome Biol. 2003;4(4):R27. Epub 2003 Mar 25.

34.

SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development.

Bussey KJ, Lawce HJ, Himoe E, Shu XO, Heerema NA, Perlman EJ, Olson SB, Magenis RE.

Genes Chromosomes Cancer. 2001 Dec;32(4):342-52.

PMID:
11746975
35.

Chromosomes 1 and 12 abnormalities in pediatric germ cell tumors by interphase fluorescence in situ hybridization.

Bussey KJ, Lawce HJ, Himoe E, Shu XO, Suijkerbuijk RF, Olson SB, Magenis RE.

Cancer Genet Cytogenet. 2001 Mar;125(2):112-8.

PMID:
11369053
36.

Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences--a Children's Cancer Group study.

Bussey KJ, Lawce HJ, Olson SB, Arthur DC, Kalousek DK, Krailo M, Giller R, Heifetz S, Womer R, Magenis RE.

Genes Chromosomes Cancer. 1999 Jun;25(2):134-46.

PMID:
10337997

Supplemental Content

Loading ...
Support Center